drugset / Trial / NCT05118672

Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment

NCT05118672

Phase 3 Completed 567 enrolled Eurofarma Laboratorios S.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

A Phase 3, multicenter, Randomized, Double-blind, comparative clinical trial to evaluate the association of paracetamol 500mg + Fexofenadine 60mg + Phenylephrine 20mg in the flu and common cold treatment. ⚠️Study will only be conducted in research centers in Brazil (please do not send e-mail if your center is outside brazil).

Timeline

Start
2025-03-26
Primary completion
2025-08-26
Completion
2025-08-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg
Subject Fexofenadine Unknown 60 mg
Subject Phenylephrine Small molecule 20 mg

Indications